Zobrazeno 1 - 10
of 449
pro vyhledávání: '"11"'
Publikováno v:
Blood. 81:27-34
We have examined the effects of recombinant human interleukin-11 (rhIL- 11) on the recovery of peripheral blood cell counts and proliferation of progenitors and hematopoietic stem cells (day 12 colony-forming units-spleen-CFU-S12) in vivo using a mou
Autor:
Shirley D'Sa, Anna Weatherill, Zara Sayar, Jonathan Sive, Mari Thomas, Stephen Keddie, Michael P. Lunn
Publikováno v:
Blood Adv
Arterial and venous thromboses occur in patients with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein level, and skin changes) syndrome at a previously reported rate of 20%. We reviewed the University College London Hospitals (UCLH) PO
Autor:
Xiaolei Wei, Haohao Lei, Yongqiang Wei, Haiqing Zheng, Ru Feng, Qifa Liu, Yunxia Zhang, Qi Wei, Xutao Guo
Publikováno v:
Blood. 138:4851-4851
Objective: Plerixafor is a small-molecule inhibitor of CXCR4. This study evaluates the efficacy of plerixafor combined with recombinant human granulocytic colony stimulating factor(G-CSF), in mobilizing hematopoietic stem cells for autologous stem-ce
Autor:
Marika Mende, Malte von Bonin, Antje Schubert, Anne Kubasch, Richard Noppeney, Marion Subklewe, Sabine Kayser, Friedrich Stoelzel, Michael Kramer, Gesine Bug, Johannes Schetelig, Gerhard Ehninger, Sebastian Stasik, Schumacher Martin, Christian Thiede, Jan-Henrik Mikesch, Juergen Novotny, Katharina Götze, Mathias Haenel, Anke Mütherig, Alwin Krämer, Dominik Wolf, Regina Herbst, Karsten Spiekermann, Lars Fransecky, Tilmann Bochtler, Uwe Platzbecker, Christoph Röllig, Carsten Müller-Tidow, Jan Moritz Middeke, Katja Sockel, Matthias Stelljes, Hubert Serve, Claudia D. Baldus, Ulrich Duehrsen, Martin Bornhäuser
Publikováno v:
Blood. 136:10-11
Background: Monitoring of measurable residual disease (MRD) in patients (pts) with advanced myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) who achieve complete remission (CR) can predict hematological relapse. Recently published data
Autor:
Stephen Peeke, Xiaoxin Ren, Lizamarie Bachier-Rodriguez, Carlo Palesi, Joan Uehlinger, Ioannis Mantzaris, Monika Paroder, Fariha Khatun, R. Alejandro Sica, Karen Fehn, Karen Wright, Alyssa DeCastro, Murali Janakiram, Shafia Rahman, Randin Nelson, Amit Verma, Richard Elkind, Susan Sakalian, Ira Braunschweig, Christopher Nishimura, Mendel Goldfinger, Yang Shi, Zhu Cui, Anjali Naik, Aditi Shastri, Kailyn Gillick, Hao Wang, Yoram A. Puius, Kira Gritsman, Astha Thakkar, Latoya Townsend-Nugent, Angelica D'Aiello, Noah Kornblum, Yanhua Wang, Margaret E McCort, Rachel Bartash, Donika Binakaj, Felisha Joseph, Rosmi Mathew, Ryann Quinn, Ulrich Steidl, Amanda Lombardo, Nicole Chambers, Michelly Abreu, Olga Derman, Xingxing Zang, Nishi Shah
Publikováno v:
Blood. 136:10-11
Background: Adoptive immunotherapy using CD19-targeted Chimeric Antigen Receptor T-cells (CAR-T) has revolutionized the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL). We have demonstrated the efficacy of FDA-approved axicabta
Publikováno v:
Blood. 134:2054-2054
Background: There are multiple treatment options that may provide symptom relief and improvement in survival in patients with primary myelofibrosis. However, allogeneic stem cell transplantation (ASCT) remains the only potentially curative option. Th
Autor:
Ernesto Ayala, Hemant S. Murthy, Ambuj Kumar, Mohamed A. Kharfan-Dabaja, Madiha Iqbal, Tea Reljic
Publikováno v:
Blood. 134:2106-2106
Background: Sickle cell disease (SCD) is an inherited hemoglobinopathy which affects over 300,000 children born each year worldwide. In spite of improvement in supportive care in recent years, there is still a lack of effective treatment options. SCD
Publikováno v:
Blood. 134:5107-5107
MDS and AML are generally not considered curable in older patients (pts) outside of allogeneic transplant. Hypomethylating agents (HMAs) have clinical activity and survival benefit in these diseases, although responses are typically not durable. Maak
Autor:
Gluckman, E., Cappelli, B., Bernaudin, F., Labopin, M., Volt, F., Carreras, J., Simoes, B. P., Ferster, A., Dupont, S., De La Fuente, J., Dalle, J. -H., Zecca, M., Walters, M. C., Krishnamurti, L., Bhatia, M., Leung, K., Yanik, G., Kurtzberg, J., Dhedin, N., Kuentz, M., Michel, G., Apperley, J., Lutz, P., Neven, B., Bertrand, Y., Vannier, J. P., Ayas, M., Cavazzana, M., Matthes-Martin, S., Rocha, V., Elayoubi, H., Kenzey, C., Bader, P., Locatelli, Franco, Ruggeri, A., Eapen, M., Bordon, V., Labarque, V., Pereira, M., Bittencourt, H., Petersen, H., Deconninck, E., Jubert, C., Perrin, J., Cahn, J. Y., Bruno, B., Bordigoni, P., Mechinaud, F., Vernant, J. P., Stephan, J. L., Suttorp, M., Strahm, B., Da Cunha, C. B., Garwer, B., Rothmayer, M., Wendelin, K., Graphakos, S., Tbakhi, A., Naeimi, N., Zuckerman, T., Sharon, P. B., Yaniv, I., Amos, T., Prete, A., Lo Nigro, L., Lanino, E., Faraci, M., Ciceri, F., Marktel, S., De Simone, G., Messina, C., Bartolomeo, P. D. I., Santarone, S., Vallisa, D., Bertaina, A., Arcese, W., Foa, R., Berger, M., Maximova, N., Wallet, S., Bazuaye, G. N., Maschan, A., De Heredia, C. D., Bieler, C. B., Pato, J. R., Heras, I., Trevor, R., Abayomi, K., Thomson, J., Fasth, A., Frodin, U., Ljugman, P., Ansari, M., Gungor, T., Unal, E., Pehlivan, M., Anak, S., Ozturk, G., Unal, A., Lawson, S., Keshani, J., Drake, A., Wynn, R., Williams, J., Jagsia, M., Leung, W., Abraham, A., Sahdey, I., Margolis, D., Eames, G., Horwitz, E., Cowan, M., Kapoor, N., Rowley, S., Megason, G., Rogers, Z., Bolanos-Meade, J., Hudspeth, M., Rosenthal, J., Olson, T., Kassow, K., Selby, G., Haines, H., Chaudhury, S.
Publikováno v:
Blood
Blood, American Society of Hematology, 2017, 129 (11), pp.1548-1556. ⟨10.1182/blood-2016-10-745711⟩
Blood, 2017, 129 (11), pp.1548-1556. ⟨10.1182/blood-2016-10-745711⟩
Blood, Vol. 129, no.11, p. 1548-1556 (2017)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Blood, American Society of Hematology, 2017, 129 (11), pp.1548-1556. ⟨10.1182/blood-2016-10-745711⟩
Blood, 2017, 129 (11), pp.1548-1556. ⟨10.1182/blood-2016-10-745711⟩
Blood, Vol. 129, no.11, p. 1548-1556 (2017)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access to care is not universal. Hematopoietic cell transplantation is, to date, the only curative therapy for SCD, but its application is limited by availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4e16b619bae1eaecb4fa9c716fda2a8
https://hdl.handle.net/10807/230050
https://hdl.handle.net/10807/230050
Autor:
Grace Perry, Genique Stanislaus, Joelle Gagnon, Yen-Hong Kuo, Danielle Marcotulli, Maritess Aviador, James K. McCloskey, Jamie Koprivnikar, Elizabeth Jones
Publikováno v:
Blood. 132:2703-2703
Background: Blinatumumab (B), a bi-specific T-cell engaging CD3-CD19 antibody construct, has shown significant activity in patients (pts) with B-cell acute lymphoblastic leukemia (B-ALL). Despite this improvement, uncertainties remain regarding the o